ロード中...

Molecular landscape and targeted therapy of acute myeloid leukemia

For decades, genetic aberrations including chromosome and molecular abnormalities are important diagnostic and prognostic factors in acute myeloid leukemia (AML). ATRA and imatinib have been successfully used in AML and chronic myelogenous leukemia, which proved that targeted therapy by identifying...

詳細記述

保存先:
書誌詳細
出版年:Biomark Res
主要な著者: Gu, Runxia, Yang, Xue, Wei, Hui
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2018
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6225571/
https://ncbi.nlm.nih.gov/pubmed/30455953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40364-018-0146-7
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!